Dive Brief: Healthcare consulting company Premier reported a 15% drop in hospital-associated sepsis cases among member hospitals over the past three years. But the news is not all good. Patients who develop sepsis in the hospital are 10% more likely to experience the worst kind, septic shock, raising the average per-case cost of treating the… Read More »
The power of positive: ARC has been instrumental for Pamela McLoughlin’s recovery from breast cancer. Photo: Damien Eagers / INM Head of Services at ARC, Patricia Pugh. Photo: Kyran O’Brien ‘This has been the hardest ‘mental marathon’ I’ve ever run’ – Dental nurse credits service for supporting her through cancer treatment Independent.ie Grief surprises. Sometimes… Read More »
FDA Approves Zulresso (brexanolone) for the Treatment of Postpartum Depression Print this page March 19, 2019 — The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD. “Postpartum depression… Read More »
A simpler way to treat TB?Malvika Verma and Karan Vishwanath By Ruby Prosser Scully If you hate taking pills, you might be excited by the invention of a coil that sits in the stomach slowly releasing medication over weeks. This could play a major role in reducing deadly tuberculosis infections and the rapidly growing problem… Read More »
Turkey provides cutting-edge medical services, including stem cell transplants, to millions – including the refugees it hosts – said a Turkish professor of hematology. Fevzi Altuntaş told Anadolu Agency (AA) that Turkey emulated developed countries in the West in its drive to offer patients high-end medical services. Altuntaş, founder of Turkish cord blood and bone… Read More »
FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD Print this page STAMFORD, Conn.–(BUSINESS WIRE) March 01, 2019 –Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announced that the U.S. Food and Drug Administration (FDA) approved Adhansia XR (methylphenidate hydrochloride) extended-release capsules CII, a central nervous system (CNS) stimulant, for… Read More »